Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
CHE US Equity
CHEMED CORP
502.71USD▲ 0.58%
Healthcare
Medical Care Facilities
96)Comparar97)Tesis →
Market Cap
$6.6B
Shares Outstanding
13M
P/E (TTM)
23.9×
P/FCF (TTM)
20.3×
Revenue (TTM)
$2.6B
Net Income (TTM)
$275M
FCF (TTM)
$323M
— Annual —FY2025
Revenue
$2.5B
Gross Margin
32.5%
Operating Margin
13.4%
Net Margin
10.5%
FCF Margin
12.9%
ROE
27.1%
ROCE
27.0%
Current Ratio
1.05
Dividend Yield
0.5%
FCF / Share
24.9
Book Value / Share
74.94
CHE US Equity
502.71USD▲ 0.58%
Tesis →

CHEMED CORP (CHE): análisis fundamental y valoración

CHEMED CORP cotiza a 502.71 USD y tiene una capitalización bursátil de $6.6B. En los últimos 12 meses ha facturado $2.6B con un margen de flujo de caja libre del 12.9%. Cotiza a 20.3 veces su flujo de caja libre (P/FCF) y a un PER de 23.9. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNYSEPaísUnited StatesEmpleados15,811Beta0.51Web↗ www.chemed.com

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offer…

Múltiplos de Valoración
P/E (Annual)
24.8×
P/E (TTM)
23.9×
P/FCF (Annual)
20.2×
P/FCF (TTM)
20.3×
EV/EBITDA
—
EV/Revenue
—
P/Sales
2.6×
P/Book
6.7×
Rentabilidad (Último Anual)
Gross Margin
32.5%
Operating Margin
13.4%
Net Margin
10.5%
FCF Margin
12.9%
ROE
27.1%
ROCE
27.0%
ROA
17.2%
Effective Tax Rate
25.4%
Métricas TTM
Revenue TTM
$2.6B
Gross Profit TTM
$859M
Operating Income TTM
$349M
Net Income TTM
$275M
FCF TTM
$323M
EPS TTM
19.88
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Current Ratio
1.05
Interest Coverage
193.3×
Working Capital
$15M
Book Value / Share
74.94
Net Debt / Share
—
Crecimiento (YoY)
Revenue YoY
+4.1%
Net Income YoY
-12.2%
FCF YoY
-11.6%
EPS Diluted YoY
-7.8%
Retorno al Accionista
Dividend Yield
0.5%
Payout Ratio
11.9%
FCF / Share
24.9
CapEx % Revenue
2.5%
Rev / Employee
160,013
Próximos Eventos
Ex-Dividendo
2026-08-17
Pago Dividendo
2026-09-03
Historial EPS
Periodo2026-102026-072026-042026-02
Real—$6.06$5.65$6.42
Estimado$6.44$5.60$5.30$7.03
Sorpresa—+8.2%+6.6%-8.7%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaCHEMediana SectorΔ
Gross Margin32.5%57.0%-24.5%
Operating Margin13.4%-38.6%+52.0%
Net Margin10.5%-33.6%+44.0%
FCF Margin12.9%-13.9%+26.7%
ROE27.1%-40.4%+67.5%
ROA17.2%-32.0%+49.3%
Current Ratio1.052.84-1.79
Debt / Equity—0.28—
Scoring Fundamental
Capital Allocation
6/ 8Sólida
✓FCF+Free cash flow positivo
✓FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✓Rev↑Revenue CAGR 3 años > 5%
✓ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✗Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)